$SYK

AI 分析

生成於 May 18, 2026

AI Score
76/ 100
Buy$SYK

Stryker Corporation

$SYKNYSEHealthcareLarge-Cap

Stryker operates as a medical technology company offering orthopedic implants, surgical equipment, and neurotechnology products worldwide.

Market Cap
$145B
Revenue (TTM)
$22.5B
+10.5%
Net Income (TTM)
$4.2B
+14.5%
EPS (TTM)
$11.25
P/E Ratio
34.2
Dividend Yield
0.9%
52-Week Range
$325-$415
Beta
0.92
Dimension Scores
Fundamental
80
Technical
72
Sentiment
76
Risk / Reward
76
Momentum
72
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
78moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $SYK

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。